首页> 外文期刊>Avian Pathology >Achievement of avian influenza virus-like particles that could be used as a subunit vaccine against low-pathogenic avian influenza strains in ducks
【24h】

Achievement of avian influenza virus-like particles that could be used as a subunit vaccine against low-pathogenic avian influenza strains in ducks

机译:可以用作鸭低致病性禽流感毒株亚单位疫苗的禽流感病毒样颗粒的实现

获取原文
获取原文并翻译 | 示例
           

摘要

Infections with H5/H7 low-pathogenic avian influenza (LPAI) viruses are now notifiable because such viruses can mutate into highly pathogenic avian influenza viruses, leading to serious problems for both animal and public health. Domestic ducks can play a crucial role in the transmission of H5 LPAI viruses to other Poultry. Although prime boost vaccination using, respectively, a recombinant vaccine and an inactivated vaccine was shown to be protective in ducks against H5N1 highly pathogenic avian influenza, vaccination of domestic ducks against H5 LPAIV is poorly documented. However, Substituting inactivated vaccines with subunit vaccines might be more advantageous. In this context, we generated a triple recombinant baculovirus composed of HA and NA proteins derived from a French H5N3 LPAI virus strain and the M protein derived from an Italian H7N1 LPAI virus strain. We describe a molecular construction strategy that enabled the development of virus-like particles (VLPs). Western blot analyses and neuraminidase inhibition assay of cell supernatants purified by Sucrose density gradient ultracentrifugation showed that HA, NA and M1 proteins were expressed and co-released. Electron microscopy examination revealed VLPs that were morphologically identical to wild-type virus. Immunogold electron microscopy demonstrated that H5 and N3 proteins were present oil the VLP surface, and haemagglutination and neuraminidase assays showed that the H and N proteins, respectively, were biologically active. In addition, VLP immunogenicity (induction of haemagglutination-inhibiting antibodies) was demonstrated in specific pathogen free Muscovy ducks. According to our successful previous experimental results of protection in ducks following vaccination with the three baculovirus-expressed proteins, the present results make feasible the reliable use of H5N3 VLPs as a subunit vaccine in this species.
机译:现在应通报H5 / H7低致病性禽流感(LPAI)病毒的感染,因为此类病毒可以突变为高致病性禽流感病毒,从而给动物和公共卫生带来严重问题。家鸭在将H5 LPAI病毒传播给其他家禽方面可以发挥关键作用。尽管显示分别使用重组疫苗和灭活疫苗的初免加强疫苗接种疫苗可在鸭子中预防H5N1高致病性禽流感,但对家鸭进行H5 LPAIV疫苗接种的文献却很少。但是,用亚单位疫苗代替灭活疫苗可能更有利。在这种情况下,我们产生了由法国H5N3 LPAI病毒株衍生的HA和NA蛋白和意大利H7N1 LPAI病毒株衍生的M蛋白组成的三重重组杆状病毒。我们描述了一种分子构建策略,可以使病毒样颗粒(VLP)的发展。通过蔗糖密度梯度超速离心纯化的细胞上清液的蛋白质印迹分析和神经氨酸酶抑制试验表明,HA,NA和M1蛋白可以表达并共释放。电子显微镜检查显示在形态上与野生型病毒相同的VLP。免疫金电子显微镜检查表明,V5表面上存在H5和N3蛋白,血凝和神经氨酸酶检测表明H和N蛋白分别具有生物活性。此外,在不含特定病原体的番鸭中也证实了VLP免疫原性(抑制血凝反应的抗体的诱导)。根据我们先前成功接种三种杆状病毒表达的蛋白质后在鸭中进行保护的实验结果,目前的结果使得在该物种中可靠使用H5N3 VLP作为亚单位疫苗是可行的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号